NCT00551629: A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002) |
|
|
| Completed | 2 | 708 | Canada | AR51 (12, 10), PR51 (3, 10), PR51 (6, 10), PR51 (6, 15) | Merck Sharp & Dohme LLC | Bacterial Infections; Virus Diseases | 03/03 | 03/03 | | |
NCT00362427: Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® |
|
|
| Completed | 2 | 460 | Canada | Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC, PR5I, PENTACEL™, NGERIX-B® | Sanofi Pasteur, a Sanofi Company, Merck Sharp & Dohme LLC | Diphtheria, Pertussis, Polio, Hepatitis B, Tetanus | 02/09 | 03/09 | | |